Ulrich Costabel
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 180 publications
Targeting CXCR6 suppresses granuloma formation and pulmonary fibrosis through inhibiting Th17 responses in sarcoidosis.
Journal: International immunopharmacology
Published: March 27, 2026
Idiopathic Pulmonary Fibrosis Risk Loci in East Asian Populations Mirror those of European Populations.
Journal: American journal of respiratory and critical care medicine
Published: June 03, 2025
Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations.
Journal: American journal of respiratory and critical care medicine
Published: June 03, 2025
Collaborative artificial intelligence and clinical evaluation of interstitial lung diseases: a call for interdisciplinary partnerships.
Journal: Science bulletin
Published: January 07, 2025
Diagnosis and Treatment of Hypersensitivity Pneumonitis: S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology.
Journal: Respiration; international review of thoracic diseases
Published: January 04, 2025
Recurrent pulmonary alveolar proteinosis after lung transplantation: a case series.
Journal: Respiratory medicine
Published: January 02, 2025
Diagnosis and Treatment of Hypersensitivity Pneumonitis - S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology
Journal: Pneumologie (Stuttgart, Germany)
Published: September 03, 2024
Serum soluble isoform of receptor for advanced glycation end product is a predictive biomarker for acute exacerbation of idiopathic pulmonary fibrosis: a German and Japanese cohort study.
Journal: Respiratory research
Published: July 23, 2024
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses: S2k Guideline of the German Respiratory Society.
Journal: Respiration; international review of thoracic diseases
Published: July 04, 2024
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
Journal: JAMA
Published: May 09, 2023
Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies.
Journal: Advances in therapy
Published: April 06, 2023
Consensus guideline on the interdisciplinary diagnosis of interstitial lung diseases
Journal: Pneumologie (Stuttgart, Germany)
Published: March 28, 2023
Last Updated: 09/26/2026